About Labviva
Labviva is a company based in Cambridge (United States) founded in 2017 by Nicholas Rioux, Aaron Miramontes, and Siamak Baharloo. Labviva has raised $55.75 million across 5 funding rounds from investors including 53 Stations, Biospring and B Capital. The company has 8 employees. Labviva offers products and services including Purchasing Platform, Inventory Management System, and Dashboard & Analytics. Labviva operates in a competitive market with competitors including Cytiva, PerkinElmer, Zageno, Fortis Life Sciences and Leica Biosystems, among others.
- Headquarter Cambridge, United States
- Employees 8
- Founders Nicholas Rioux, Aaron Miramontes, Siamak Baharloo
- SectorsHealthcare
- Website labviva.com
- Social LinkedIn X
- Legal Name Labviva, Inc.
- Total Equity Funding$55.75M (USD)
in 5 rounds
- Latest Funding Round$25M (USD), Series B
Jan 2025
- Investors53 Stations
& 4 more
- Employee Count8
Products & Services of Labviva
Labviva offers a comprehensive portfolio of products and services, including Purchasing Platform, Inventory Management System, and Dashboard & Analytics.
Platform for optimizing life sciences spend and supplier integration.
Automates stock tracking and reduces costs in life sciences operations.
Provides real-time data insights for purchasing and inventory decisions.
Funding Insights of Labviva
Labviva has successfully raised a total of $55.75M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $25 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $55.75M
- Total Rounds 5
- Last Round Series B — $25M
- First Round $750,000
(May 2019)
- Investors Count 5
All 5 funding rounds of Labviva with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2025 | $25M | Series B | – | 53 Stations | |
| Mar 2023 | $20M | Series A | – | Biospring Partners | |
| Jun 2021 | $8M | Seed | – | Senator Investment Group | |
| Jun 2020 | $2M | Seed | – | – | – |
| May 2019 | $750,000 | Seed | – | – | – |
5 investors in total: 5 institutional.
Investors in Labviva
Labviva has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include 53 Stations, Biospring and B Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage venture capital investments are provided by 53 Stations. | – | 53stations.com | Chicago, United States | |
Biospring is engaged in partnering with pharma services businesses. | – | biospring.com | New York, United States | |
Multistage investments are directed toward technology, healthcare, and climate sectors. | – | b.capital | Manhattan Beach, United States | |
Early-stage investments are made in AI and frontier technology startups by Glasswing Ventures. | – | glasswing.vc | Boston, United States | |
Private equity & fixed income investments focused hedge fund | – | senatorlp.com | New York, United States |
Investor details for Labviva
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Labviva
40 people are tracked at Labviva (16 in leadership, 24 in team); the tracked headcount is 8.
| Name | Role | Group |
|---|---|---|
Nicholas Rioux | Co-Founder & CTO | Leadership |
Aaron Miramontes | Co-Founder & CPO | Leadership |
Siamak Baharloo | Co-Founder & CEO | Leadership |
Gjergji Progri | Director Of Finance | Leadership |
Ginay Tannenbaum | Senior Director of People | Leadership |
Neal Karasic | Vice President, Product | Leadership |
Julie Tagliamonte | VP, Client & Customer Services | Leadership |
Chris Lope | Sr. Vice President | Leadership |
Lani Wright | Director, Education And Enablement | Leadership |
Jonathan Sheffi | Vice President of Strategic Marketing | Leadership |
Anita Wells | Director, Business Development | Leadership |
Zach Sanders | Director Of Engineering | Leadership |
Rich Miceli | Vice President Of Business Development | Leadership |
Lirong F. | Vp, Analytics And Data Science | Leadership |
Maisie Mahoney | Vp, Business Operations | Leadership |
Rick Eichhorn | Director Of Product Management | Leadership |
Giovany Tovar Celona | Data Science Manager | Platform & Product Engineering | Team |
Arielle Rosenthal | Senior Engineer | Team |
Emily Czarnecki | Engineering Manager | Team |
Vadim Beliak | Senior Software Engineer | Team |
20 more people are available in the full profile.
Complete people profiles for Labviva
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Labviva
3 dated milestones of Labviva across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Labviva is founded.
- Funding First funding round of $750K.
- Funding Latest funding round, Series B, of $25.0M.
Competitors of Labviva
Labviva operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cytiva, PerkinElmer, Zageno, Fortis Life Sciences and Leica Biosystems, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cytivalifesciences.com | 1968 | Sheffield, United Kingdom | – | 578 | Life science software and research products are provided online. | |
| perkinelmer.com | 1931 | Waltham, United States | – | 219 | Medical instruments and supplies are manufactured and provided for healthcare. | |
| zageno.com | 2015 | Cambridge, United States | $120.93M | 51 | Marketplace and life science research community for biotech research kits | |
| fortislife.com | 2020 | Waltham, United States | – | – | A trusted partner in life sciences and diagnostics solutions. | |
| leicabiosystems.com | 1989 | Nussloch, Germany | – | 365 | Provides tools for anatomic pathology, histology, and digital cancer diagnostics worldwide. | |
| meenta.io | 2016 | Boston, United States | $2.47M | – | Operates a digital marketplace for sequencing instruments. | |
| celltreat.com | 2008 | Pepperell, United States | – | – | Produces laboratory plastic consumables like pipets and vials for efficient scientific research. |
Detailed competitors of Labviva
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Labviva
The website of Labviva (labviva.com) receives about 15.1K visits a month.
- Monthly visits15.1K
▲ 12.2% vs previous month
Websites whose visitors overlap most with Labviva. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| nature.com | 100% | 33.6M | #1,922 | View details | |
| researchgate.net | 65% | 101.7M | #345 | View details | |
| avantorsciences.com | 60% | 564.1K | #77,334 | View details | |
| sigmaaldrich.com | 52% | 4.4M | #15,208 | View details | |
| fishersci.com | 43% | 1.8M | #30,987 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for Labviva
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Labviva
Complete news archive for Labviva
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Labviva
10 companies that operate in the same segment as Labviva (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Labviva
Labviva was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Labviva is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Siamak Baharloo is the current CEO of Labviva. They have also founded this company.
Labviva is a funded company, having raised a total of $55.75M across 5 funding rounds to date. The company's 1st funding round was a Seed of $750K, raised on May 2019.
Labviva has 8 employees.
Labviva was founded in 2017 in Cambridge, United States. An AI-powered digital marketplace is maintained to connect researchers with suppliers of reagents, chemicals, and instrumentation within the life sciences sector. Procurement systems are integrated to facilitate transactions. Operations focus on streamlining access to essential lab materials across the industry.
Labviva's top competitors include Cytiva, Zageno and PerkinElmer.
Labviva offers Purchasing Platform, Inventory Management System, and Dashboard & Analytics.
Labviva has 5 investors. Key investors include 53 Stations, Biospring, B Capital, Glasswing Ventures, and Senator Investment Group.
Labviva operates through Labviva, Inc..